HY-100403-10mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-100mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-2mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-25mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-5mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-50mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-101986-10mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-100mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-25mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-5mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-50mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-108483-10mg
|
MedChemexpress LLC
|
RP 67580 [CAS 135911-02-3]
|
|
|
|
HY-108483-5mg
|
MedChemexpress LLC
|
RP 67580 [CAS 135911-02-3]
|
|
|
|
HY-118463-1mg
|
MedChemexpress LLC
|
Benzomalvin A [CAS 157047-96-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-126326-10mg
|
MedChemexpress LLC
|
SWE101 [CAS 2376322-12-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-126326-100mg
|
MedChemexpress LLC
|
SWE101 [CAS 2376322-12-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-126326-25mg
|
MedChemexpress LLC
|
SWE101 [CAS 2376322-12-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-126326-5mg
|
MedChemexpress LLC
|
SWE101 [CAS 2376322-12-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-126326-50mg
|
MedChemexpress LLC
|
SWE101 [CAS 2376322-12-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-13543-10mg
|
MedChemexpress LLC
|
Tretazicar [CAS 21919-05-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-13543-25mg
|
MedChemexpress LLC
|
Tretazicar [CAS 21919-05-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-13543-5mg
|
MedChemexpress LLC
|
Tretazicar [CAS 21919-05-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-13543-50mg
|
MedChemexpress LLC
|
Tretazicar [CAS 21919-05-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-14280-10mg
|
MedChemexpress LLC
|
Entacapone [CAS 130929-57-6]
|
|
Neuroscience-Neurodegeneration
|
|
HY-14280-100mg
|
MedChemexpress LLC
|
Entacapone [CAS 130929-57-6]
|
|
Neuroscience-Neurodegeneration
|
|